Terumo Corporation (FRA:TUO0)

Market Cap	20.15B -7.4%
Revenue (ttm)	6.37B +14.0%
Net Income	885.81M +31.7%
EPS	0.63 +31.9%
Shares Out	n/a
PE Ratio	20.65
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	13.10
Previous Close	13.20
Day's Range	13.10 - 13.10
52-Week Range	9.75 - 14.20
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 12, 2026

About Terumo

Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through four segments: Cardiac and Vascular Company, Medical Care Solutions Company, Blood and Cell Technologies Company, and Terumo Organ Technologies. The Cardiac and Vascular Company segment offers angiographic guidewires, angiographic catheters, introducer sheaths, vascular closure devices, PTCA balloon catheters, coronary stents, self-expanding peripheral stents...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1921
• Employees: 30,591
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: TUO0

Financial Performance

In fiscal year 2026, Terumo's revenue was 1.13 trillion, an increase of 9.24% compared to the previous year's 1.04 trillion. Earnings were 135.91 billion, an increase of 16.19%.

Financial numbers in JPY

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error